DCF — ST MARYS REGL MEDICAL CENTER
Enterprise Value: $-82.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-82.7M
Enterprise Value
$-27.8M
PV of Cash Flows
$-55.0M
PV of Terminal Value
$-88.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $99.1M | $-4.3M | -4.0% | $-8.5M | $-7.7M |
| Year 2 | $102.1M | $-3.4M | -3.0% | $-7.7M | $-6.4M |
| Year 3 | $105.2M | $-2.4M | -2.0% | $-6.9M | $-5.2M |
| Year 4 | $108.3M | $-2.0M | -2.0% | $-6.6M | $-4.5M |
| Year 5 | $111.6M | $-1.8M | -2.0% | $-6.5M | $-4.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-82.7M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$96.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.0482027536321111
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5